Free Trial
CVE:ADK

DIAGNOS (ADK) Stock Price, News & Analysis

DIAGNOS logo
C$0.32
0.00 (0.00%)
(As of 03:59 PM ET)

About DIAGNOS Stock (CVE:ADK)

Key Stats

Today's Range
C$0.32
C$0.33
50-Day Range
C$0.32
C$0.40
52-Week Range
C$0.23
C$0.57
Volume
79,500 shs
Average Volume
90,376 shs
Market Capitalization
C$26.06 million
P/E Ratio
N/A
Dividend Yield
0.29%
Price Target
C$1.50
Consensus Rating
Strong Buy

Company Overview

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Stock News Headlines

ADK:CA DIAGNOS Inc.
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Got $1,000? 2 Stocks to Buy Now While They’re on Sale
DIAGNOS recognized as a Top TSX Venture Exchange Company
Closing Bell: Diagnos Inc flat on Thursday (ADK)
See More Headlines

ADK Stock Analysis - Frequently Asked Questions

DIAGNOS's stock was trading at C$0.41 on January 1st, 2024. Since then, ADK stock has decreased by 21.0% and is now trading at C$0.32.
View the best growth stocks for 2024 here
.

DIAGNOS Inc. (CVE:ADK) issued its earnings results on Wednesday, August, 21st. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.01. The firm earned $0.04 million during the quarter, compared to analysts' expectations of $0.07 million.

Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that DIAGNOS investors own include DIAGNOS (DGNOF), Facedrive (FDVRF), New Found Gold (NFGC), Ackroo (AKR), BeWhere (BEW), BlueRush (BTV) and Grande West Transportation Group (BUS).

Company Calendar

Last Earnings
8/21/2024
Today
11/05/2024
Next Earnings (Estimated)
11/26/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$1.50
High Stock Price Target
C$1.50
Low Stock Price Target
C$1.50
Potential Upside/Downside
+368.8%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

Net Income
C$-3,090,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$577,486.00
Cash Flow
C$0.01 per share
Book Value
C($0.03) per share

Miscellaneous

Free Float
N/A
Market Cap
C$26.06 million
Optionable
Not Optionable
Beta
-0.44
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:ADK) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners